SCHADE CHRISTIAN S 4
4 · Aprea Therapeutics, Inc. · Filed May 19, 2022
Insider Transaction Report
Form 4
SCHADE CHRISTIAN S
DirectorPresident & CEO
Transactions
- Purchase
Common Stock
2022-05-18$0.64/sh+37,500$24,124→ 292,616 total
Holdings
- 1,000(indirect: By Children)
Common Stock
- 1,000(indirect: By Children)
Common Stock
- 1,000(indirect: By Children)
Common Stock
- 1,000(indirect: By Children)
Common Stock
- 5,000(indirect: By Spouse)
Common Stock
- 1,000(indirect: By Children)
Common Stock
- 1,000(indirect: By Children)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.6245 to $0.6675, inclusive. The reporting person undertakes to provide Aprea Therapeutics, Inc., any security holder of Aprea Therapeutics, Inc., or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F2]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, or for any other purpose.